Explore

Trendline Trendline
CenExel Appoints Dr. Sy Pretorius as New CEO to Drive Strategic Growth

CenExel Appoints Dr. Sy Pretorius as New CEO to Drive Strategic Growth

CenExel Appoints Dr. Sy Pretorius as New CEO to Drive Strategic Growth
Trendline Trendline
CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth

CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth

CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth
Trendline Trendline
Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research

Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research

Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research
Trendline Trendline
Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported

Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported

Cingulate's ADHD Drug Faces FDA Manufacturing Review, No Safety Concerns Reported
Trendline Trendline
Sanofi's Lunsekimig Shows Promise in Asthma and Rhinosinusitis, Falls Short in Eczema Trial

Sanofi's Lunsekimig Shows Promise in Asthma and Rhinosinusitis, Falls Short in Eczema Trial

Sanofi's Lunsekimig Shows Promise in Asthma and Rhinosinusitis, Falls Short in Eczema Trial
Trendline Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies
Trendline Trendline
Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Skin Conditions

Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Skin Conditions

Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Skin Conditions
Trendline Trendline
HIG Capital Appoints New CEO Amid Leadership Restructuring

HIG Capital Appoints New CEO Amid Leadership Restructuring

HIG Capital Appoints New CEO Amid Leadership Restructuring
Trendline Trendline
HIG Capital Appoints New CEO Amid Leadership Changes

HIG Capital Appoints New CEO Amid Leadership Changes

HIG Capital Appoints New CEO Amid Leadership Changes
Trendline Trendline
Allucent Expands Leadership to Enhance Drug Development for Biopharma

Allucent Expands Leadership to Enhance Drug Development for Biopharma

Allucent Expands Leadership to Enhance Drug Development for Biopharma
Trendline Trendline
Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements

Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements

Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements
Trendline Trendline
Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights